SKINCARE IS SHIFTING FROM BOTTLES TO JARS. SUPPLEMENTS ARE THE NEW SERUM?.
We need to talk about the supplements trend.
Because "supplements are the new serums" is only half the story and the half that's missing is costing people results.
Monoskin Intelligence · Skincare Science · 8 min read
We've been sitting with this one for a while.
For the past year or so, we've been watching a narrative build across skincare communities on Instagram, in wellness spaces, in product launches that goes something like this: topical skincare is the old way. Supplements are the future. What you put in your body matters more than what you put on it.
And look, we get the appeal. We really do. After years of being told that the right serum would fix everything, there's something refreshing about a conversation that acknowledges the skin is connected to the rest of the body. Because it is. That part is true.
But here's what bothers us: the conversation has turned into an either/or. And the moment it became either/or, it stopped being science and started being marketing.
We started Monoskin Intelligence because we believed that skincare deserved more honesty more rigour than the trend cycle usually allows for. So this is us doing that.
This is the full picture on topicals vs ingestibles. Not a trend piece. Not a product pitch. Just what the science actually says, and what we think it means for anyone who takes their skin seriously.
The skin is a two-direction organ. It faces outward. It is fed from within. Any approach that treats only one direction is, by definition, incomplete.
First what the supplements conversation got right
We want to be fair here, because the turn toward ingestible skincare didn't happen in a vacuum. There are real, documented reasons why what you consume affects your skin and for a long time, mainstream skincare largely ignored this.
Vitamin D insufficiency runs at over 40% in Indian adults, by some clinical estimates. Zinc deficiency shows up in roughly a quarter of acne patients in published studies. Essential fatty acid imbalances are genuinely common in diets high in processed foods. These deficiencies don't just affect general health they show up on the skin as impaired barrier function, slower healing, and heightened inflammatory responses.
Oral collagen peptides have real, replicated evidence behind them multiple randomised controlled trials showing measurable improvements in skin hydration, elasticity, and dermal density at 8 to 12 weeks of consistent use. Omega-3 fatty acids have demonstrated anti-inflammatory effects relevant to acne and atopic dermatitis. Probiotics, in well-designed trials, have reduced inflammatory lesion counts in acne-prone patients.
So the ingestibles conversation wasn't wrong. It was just incomplete.
WORTH KNOWING
The gut-skin axis the relationship between gut microbiome health and skin inflammation is one of the most rapidly growing areas of dermatology research. Conditions like rosacea, acne, and atopic dermatitis all show documented links to gut dysbiosis. This is peer-reviewed science, not wellness marketing.
Here's what the trend missed and why it matters
Topical skincare has a superpower that ingestibles simply don't have. It is site-specific.
Think about what that actually means. When a dermatologist prescribes tretinoin, it lands exactly where it needs to in the follicle, at the keratinocyte, in the zone where comedones form and where collagen synthesis can be stimulated. The concentration at the target tissue is controlled. The rest of the body is largely unaffected. That precision is not a small thing.
We've spoken to dermatologists who put it bluntly: a supplement cannot be directed to the left side of your chin. A topical can.
And then there's the pharmacology reality that rarely gets mentioned in trend content: tretinoin taken orally at concentrations that would match topical efficacy is systemically toxic. That's why isotretinoin the oral retinoid is a controlled prescription with mandatory blood monitoring. The molecule is the same. The delivery route changes everything.
|
Ingredient |
What it does topically |
Is there an oral version? |
|
Tretinoin |
Keratinocyte turnover, comedolysis, collagen remodelling at tissue level |
Only as isotretinoin — a controlled drug, not a supplement |
|
Azelaic acid |
Tyrosinase inhibition directly at the melanocyte, antimicrobial at follicle |
No oral equivalent exists |
|
Niacinamide |
Sebum regulation, ceramide production, barrier repair |
Some systemic overlap at very high oral doses |
|
Clindamycin |
Targets C. acnes bacteria directly at the follicular surface |
Oral form carries full systemic antibiotic risk |
|
Adapalene |
Comedolysis and anti-inflammatory — retinoid receptor selective |
No therapeutic oral equivalent available |
This matters even more for Indian skin
For Fitzpatrick IV to VI skin types which describes the majority of Indian patients topical precision is not just helpful. It's essential.
Post-inflammatory hyperpigmentation is one of the most common, most distressing concerns we hear about from people across India. It happens faster in darker phototypes, runs deeper, and persists longer than in lighter skin. The mechanism is epidermal it happens in a specific location. And the most effective interventions for it tyrosinase inhibitors, retinoids, azelaic acid work because they're delivered directly to that specific location.
No supplement can do that. No supplement is even trying to do that.
The gut-skin axis where ingestibles genuinely win
Here's where we want to push back on conventional skincare too, because this part of the story often gets dismissed by people who are sceptical of the supplements trend.
The gut-skin axis is real. Gut dysbiosis an imbalance in the gut microbiome has documented associations with acne severity, rosacea flares, and atopic dermatitis severity. The pathway runs through intestinal permeability, systemic immune signalling, and the regulation of inflammatory markers in the blood.
We've heard versions of the same story from people who have written to us: cycling through topical protocol after topical protocol, seeing modest improvement, then plateauing. In many of those cases, what changed the picture wasn't a new serum it was addressing what was happening internally.
And this is where we have to be direct: a topical cannot fix a gut problem. The pathway runs inward. Applying something to the skin surface cannot modulate the jejunal microbiome. These are different systems that require different interventions.
We've come to believe that the patient who has failed three topical protocols doesn't need a fourth one. They need a different conversation entirely.
|
WHAT WE THINK IS BEING MISSED IN INDIA High antibiotic use, chronic stress, irregular eating, and limited access to consistently probiotic-rich foods in urban Indian diets mean that gut-driven skin inflammation is likely far more common than current dermatology practice acknowledges. This is an area we're watching closely. |
So what does a complete protocol actually look like?
This is the question we keep coming back to. Not which approach is better but how they work together.
Because when you understand what each one is actually doing, the answer becomes obvious. They're not competing. They're working at different depths, on different timescales, through different mechanisms. A complete skin health protocol needs both arms.
Let's make it concrete post-laser care
Think about the 72 hours after an ablative laser treatment. What is the skin actually asking for?
• Barrier-protective topicals to prevent trans-epidermal water loss and secondary infection at the wound surface
• Targeted actives to manage post-inflammatory pigmentation risk critical in darker phototypes
• Vitamin C supplementation to support collagen synthesis from within
• Zinc to accelerate wound healing at the cellular level
• Adequate protein intake because the body is literally rebuilding tissue
Take either arm away and you're leaving recovery on the table. Not as a philosophy
as biology
And for acne the same logic
A complete acne protocol in 2026 should be addressing at least three distinct levels of the problem:
• The follicle itself — with a topical retinoid and/or antimicrobial
• The systemic inflammatory environment — with dietary adjustments and omega-3 support
• The gut-skin axis — with probiotic support and a harder look at antibiotic dependence
None of these substitutes for another. They're targeting different parts of the same pathophysiology. The acne is one problem with multiple roots and the best protocols address each root with the right tool.
|
Approach |
Works on |
Timeline |
Cannot replace |
|
Topical |
Specific tissue targets — follicle, melanocyte, epidermis |
Hours to days |
Systemic deficiencies, gut-axis inflammation |
|
Ingestible |
Systemic environment — inflammation, nutrition, microbiome |
Weeks to months |
Site-specific action, local delivery |
|
Both together |
Full depth — local and systemic simultaneously |
Both timescales |
Nothing. This is the complete picture. |
Why we're writing this
We're not writing this to sell you anything. We're writing it because we think the skincare conversation in India deserves more honesty than the trend cycle usually offers.
The supplements narrative has done one genuinely useful thing: it's opened up a conversation about the skin as a whole-body concern, not just a surface to be managed. That is a good shift. We're glad it happened.
But somewhere along the way, it started positioning itself as a replacement for topical science and that's where we get off the bus.
The skin is fed from both directions. Topicals treat the tissue. Ingestibles support the system. Neither is optional. Neither is the future. Both are the present.
The brands and dermatologists who understand this who build protocols that address the skin at every level are going to produce results that trend-hopping never will.
That's the standard we hold ourselves to at Monoskin. And it's the standard we think you deserve.
Supplements are not the new serums. They are the other half of the protocol we should have been completing all along.